We provide you with 20 years of free, institutional-grade data for VYNT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VYNT. Explore the full financial landscape of VYNT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about VYNT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vyant Bio Inc(NASDAQ:VYNT) 
Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk ...
Website: https://www.vyantbio.com/
Founded: 1999
CEO: Jay Roberts
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Share this website to your friends